HELX vs. FGDL
HELX (Franklin Genomic Advancements ETF) and FGDL (Franklin Responsibly Sourced Gold ETF) are both exchange-traded funds - HELX is a Health & Biotech Equities fund actively managed by Franklin Templeton, while FGDL is a Gold fund tracking the LBMA Gold Price PM ($/ozt). HELX is actively managed, while FGDL is passively managed. Over the past 3 years, HELX returned 7.14%/yr vs 28.79%/yr for FGDL. At a 0.20 correlation, their price movements are largely independent. HELX charges 0.50%/yr vs 0.15%/yr for FGDL.
Performance
HELX vs. FGDL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HELX achieves a 0.89% return, which is significantly higher than FGDL's -4.86% return.
HELX
- 1D
- 0.84%
- 1M
- 7.10%
- YTD
- 0.89%
- 6M
- -0.79%
- 1Y
- 35.07%
- 3Y*
- 7.14%
- 5Y*
- -5.27%
- 10Y*
- —
FGDL
- 1D
- -1.86%
- 1M
- -8.58%
- YTD
- -4.86%
- 6M
- -8.67%
- 1Y
- 21.26%
- 3Y*
- 28.79%
- 5Y*
- —
- 10Y*
- —
HELX vs. FGDL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
HELX Franklin Genomic Advancements ETF | 0.89% | 26.34% | -5.32% | 1.14% | -6.18% |
FGDL Franklin Responsibly Sourced Gold ETF | -4.86% | 64.15% | 27.31% | 12.92% | 0.72% |
Correlation
The correlation between HELX and FGDL is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Jun 30, 2022 | 0.20 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HELX vs. FGDL — Risk / Return Rank
HELX
FGDL
HELX vs. FGDL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Franklin Genomic Advancements ETF (HELX) and Franklin Responsibly Sourced Gold ETF (FGDL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HELX | FGDL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.88 | ||
| Sortino ratioReturn per unit of downside risk | +1.25 | ||
| Omega ratioGain probability vs. loss probability | 1.28 | 1.16 | +0.12 |
| Calmar ratioReturn relative to maximum drawdown | 1.96 | 0.86 | +1.09 |
| Martin ratioReturn relative to average drawdown | 4.96 | 2.31 | +2.65 |
Loading charts...
Drawdowns
HELX vs. FGDL - Drawdown Comparison
The maximum HELX drawdown since its inception was -58.75%, which is greater than FGDL's maximum drawdown of -24.73%. Use the drawdown chart below to compare losses from any high point for HELX and FGDL.
Loading charts...
Drawdown Indicators
| HELX | FGDL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.75% | -24.73% | -34.02% |
Max Drawdown (1Y)Largest decline over 1 year | -18.01% | -24.73% | +6.72% |
Max Drawdown (3Y)Largest decline over 3 years | -29.48% | -24.73% | -4.75% |
Max Drawdown (5Y)Largest decline over 5 years | -58.75% | — | — |
Current DrawdownCurrent decline from peak | -36.69% | -23.98% | -12.71% |
Average DrawdownAverage peak-to-trough decline | -34.33% | -4.07% | -30.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.09% | 9.24% | -2.15% |
Volatility
HELX vs. FGDL - Volatility Comparison
The current volatility for Franklin Genomic Advancements ETF (HELX) is 6.84%, while Franklin Responsibly Sourced Gold ETF (FGDL) has a volatility of 8.47%. This indicates that HELX experiences smaller price fluctuations and is considered to be less risky than FGDL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HELX | FGDL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.84% | 8.47% | -1.63% |
Volatility (6M)Calculated over the trailing 6-month period | 16.93% | 24.48% | -7.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.37% | 27.83% | -6.46% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.14% | 19.33% | +4.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.36% | 19.33% | +8.03% |
HELX vs. FGDL - Expense Ratio Comparison
HELX has a 0.50% expense ratio, which is higher than FGDL's 0.15% expense ratio.
Dividends
HELX vs. FGDL - Dividend Comparison
HELX's dividend yield for the trailing twelve months is around 0.39%, while FGDL has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
FGDL Franklin Responsibly Sourced Gold ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
HELX Franklin Genomic Advancements ETF | 0.39% | 0.39% | 0.00% | 0.00% | 0.00% | 0.24% | 0.12% |
Frequently Asked Questions
HELX and FGDL have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FGDL has higher volatility (8.47%) compared to HELX (6.84%). In terms of maximum drawdown, HELX dropped -58.75% vs FGDL's -24.73%.
On 3-year performance, FGDL leads with 28.79% vs 7.14% for HELX. On fees, FGDL is cheaper at 0.15% per year. On volatility, HELX has been the lower-risk option at 6.84%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, FGDL has performed better with a 28.79% return vs 7.14%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FGDL is cheaper with a 0.15% expense ratio, compared with 0.50% for HELX.
HELX has the higher dividend yield at 0.39%, compared with 0.00% for FGDL.
HELX is categorized as Health & Biotech Equities, while FGDL is Gold. Their fees differ too: 0.50% for HELX and 0.15% for FGDL.
HELX currently has the higher Sharpe Ratio (1.65 vs 0.77), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HELX and FGDL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer